Effectiveness of Darvyadi Kwath and Nishamlaki Churna in Diabetes Mellitus

Phase 4

• Conditions: Health Condition 1: E119- Type 2 diabetes mellitus without complications

• Registration Number: CTRI/2022/04/042107
• Lead Sponsor: Chaudhary Brahm Prakash Ayurved Charak Sansthan

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 2 May 2022

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Patients fulfilling the diagnostic criteria for Diabetes Mellitus framed by the AMERICAN DIABETES ASSOCIATION.

2. FBS-126-250mg/dl

3. PPBS 180-400mg/dl

4. HbA1c 6.4 % and more.

5.Patient is taking anti oral diabetic medicine sulphonylureas dosage (glipizide not more then 20mg, glimipride not more then 8mg, glidazidie not more than 180 mg, pioglitazoe not more than 20 mg

) and bigunoids (metformin not more than 1000 mg)

6. Diagnosed case of Diabetes mellitus at least 6 month back

Exclusion Criteria

1. Patients below the age of 21 years and more than the age of 60 years.

2. Fasting Blood Sugar Level >250 mg/dl •

3. Post Prandial Blood Sugar Level >400 mg/dl

4. HbA1c >10%

5. Patients depending on the insulin for blood glucose control.

6. Patients with diabetic complications.

7. Patients suffering from Secondary Diabetes.

8. Gestational diabetes.

9. Pregnant ladies and lactating mothers.

10. Patient is taking any other oral anti diabetic medicine or combination of any oral anti diabetic medicine.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction in the value of FBS, Glucose in urine and HBA1CTimepoint: Day1, Day28, Day56, Day84

Secondary Outcome Measures

Name	Time	Method
Improvement in graded symptom of Dhatusamyata andVikaropshama MadhumehaTimepoint: Day1, Day28, Day56, Day84